Glucose Baxter (Glucose)

Glucose Baxter is used in clinical settings where rapid delivery of carbohydrate is required. Intravenous glucose can help restore normal blood sugar levels and provide immediate energy to cells.

• Management of acute hypoglycemia in hospital settings.
• Support during surgical procedures to maintain glucose homeostasis.
• Provision of caloric supplementation for patients unable to eat orally.
• Part of fluid therapy regimens for dehydration with electrolyte imbalance.
• Adjunct in diagnostic tests requiring glucose infusion.

Side effects associated with intravenous glucose vary by dose and patient condition. Most reactions are mild, but some may require medical attention.

Common

• Transient hyperglycemia.
• Local irritation at the infusion site.
• Nausea or mild vomiting.
• Headache.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Allergic reaction such as rash or urticaria.
• Fluid overload causing pulmonary edema.
• Electrolyte disturbances (e.g., hyponatremia).

When using Glucose Baxter, clinicians should consider several precautionary measures to ensure patient safety.

• Verify patient’s blood glucose level before administration.
• Adjust dose in patients with renal or cardiac insufficiency.
• Monitor for signs of hyperglycemia during and after infusion.
• Use aseptic technique to prevent contamination.
• Avoid rapid infusion rates that may cause circulatory overload.
• Assess for known glucose intolerance or metabolic disorders.

Glucose Baxter may interact with other medications or solutions administered concurrently.

Avoid

• Co-administration with high‑dose insulin without appropriate glucose monitoring.
• Simultaneous infusion of potassium chloride solutions that may precipitate.

Use with caution

• Concurrent use of diuretics that affect fluid balance.
• Medications that influence blood glucose, such as oral hypoglycemics.
• Electrolyte‑containing IV fluids that could alter serum sodium or potassium levels.